AI-generated summary
The authors report a randomized, double-blinded, sham-controlled crossover trial of 70 patients with chemotherapy-induced peripheral neuropathy. Photobiomodulation was associated with significant reductions in neuropathy scores at all time points, while sham treatment showed no significant change, and adding physiotherapy did not improve outcomes further.
- Participants
- 70
- Who or what was studied
- Patients with chemotherapy-induced peripheral neuropathy
- Limits stated in the abstract
- The abstract does not report the wavelength or dosing parameters of the light, and it does not describe the size of any control group beyond the sham arm.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Sham, Neuropathy. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.